Biogened Dividende

Zukünftiges Wachstum Kriterienprüfungen 2/6

Biogened is a dividend paying company with a current yield of 2.14% that is well covered by earnings. Next payment date is on 18th November, 2024 with an ex-dividend date of 12th September, 2024.

Wichtige Informationen

2.1%

Dividendenausschüttung

n/a

Rückkaufsrendite

Gesamte Aktionärsrenditen/a
Zukünftige Dividendenrenditen/a
Wachstum der Dividenden/a
Nächster Dividendenzahlungstermin18 Nov 24
Ex-Dividendendatum12 Sep 24
Dividende pro Aktiezł0.500
Ausschüttungsquote23%

Aktuelle Dividendenentwicklung

Recent updates

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Whilst dividend payments have been stable, BGD has been paying a dividend for less than 10 years.

Wachsende Dividende: BGD's dividend payments have increased, but the company has only paid a dividend for 3 years.


Dividendenrendite im Vergleich zum Markt

Biogened Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von BGD im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (BGD)2.1%
Untere 25 % des Marktes (PL)2.8%
Markt Top 25 % (PL)8.0%
Branchendurchschnitt (Pharmaceuticals)2.4%
Analystenprognose (BGD) (bis zu 3 Jahre)n/a

Bemerkenswerte Dividende: BGD's dividend (2.14%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.82%).

Hohe Dividende: BGD's dividend (2.14%) is low compared to the top 25% of dividend payers in the Polish market (7.96%).


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: With its low payout ratio (22.9%), BGD's dividend payments are well covered by earnings.


Barausschüttung an die Aktionäre

Cashflow-Deckung: With its reasonably low cash payout ratio (30.1%), BGD's dividend payments are well covered by cash flows.


Entdecken Sie dividendenstarke Unternehmen